Viral Immunology

Papers
(The TQCC of Viral Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19113
The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses37
Interleukin-1in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective33
Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients32
Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-1929
Levamisole Therapy in COVID-1927
Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons26
Parvovirus Capsid-Antibody Complex Structures Reveal Conservation of Antigenic Epitopes Across the Family21
How to Understand Herd Immunity in the Context of COVID-1916
Coronavirus Disease 2019 Vaccine Development: An Overview16
Lack of Effects of the Genetic Polymorphisms of Interleukin-10 in Clinical Outcomes of COVID-1915
Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-1913
Probiotic Lactobacilli Enhance Immunogenicity of an Inactivated H9N2 Influenza Virus Vaccine in Chickens12
Cytokine Storm May Not Be the Chief Culprit for the Deterioration of COVID-1912
Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-γas a Novel Antiviral Ap12
Structural Perspectives of Beak and Feather Disease Virus and Porcine Circovirus Proteins11
Activation of Interleukin-1β Release and Pyroptosis by Transmissible Gastroenteritis Virus Is Dependent on the NOD-Like Receptor Protein 3 Inflammasome in Porcine Intestinal Epithelial Cell Lin11
The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis11
T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications11
Human Cytomegalovirus Infection and Cardiovascular Disease: Current Perspectives10
The Role of Tape Measure Protein in Nucleocytoplasmic Large DNA Virus Capsid Assembly8
Transcriptomic Analysis of Interferon Response in Toll-Like Receptor 2 Ligand-Treated and Herpes Simplex Virus 1-Infected Neurons and Astrocytes8
SARS-CoV-2 and Guillain–Barré Syndrome: Lessons from Viral Infections8
Dysfunctional State of T Cells or Exhaustion During Chronic Viral Infections and COVID-19: A Review7
Immunity Debt, a Gap in Learning, or Immune Dysfunction?7
Controlling the Burden of COVID-19 by Manipulating Host Metabolism7
Enterovirus 2C Protein Suppresses IKKα Phosphorylation by Recruiting IKKβ and IKKα into Viral Inclusion Bodies7
IFITMs of African Green Monkey Can Inhibit Replication of SFTSV but Not MNV In Vitro7
Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors7
Generation and Evaluation of Recombinant Baculovirus Coexpressing GP5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus Type 16
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Sec6
Cytokine, Genotype, and Viral Load Profile in the Acute and Chronic Hepatitis B6
Omicron: A Speculation on Its Potential Superpowers6
Combination and Intermittent Therapy Based on Pegylated Interferon Alfa-2a for Chronic Hepatitis B with Nucleoside (Nucleotide) Analog-Experienced Resulting in Hepatitis B Surface Antigen Clearance: A6
Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients6
Elevated Plasma Fractalkine Level Is Associated with the Severity of Hemorrhagic Fever with Renal Syndrome in Humans6
Immunosenescence and Inflammaging in COVID-196
Human Eosinophils Reduce Viral Titer, Secrete IL-8, and Increase RIG-I Expression in Response to Influenza A H1N1 pdm096
Tocilizumab-Induced Unexpected Increase of Several Inflammatory Cytokines in Critically Ill COVID-19 Patients: The Anti-Inflammatory Side of IL-66
Epidemiology of Porcine Pseudorabies from 2010 to 2018 in Tianjin, China6
Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure6
New Avenues to Explore in SARS-CoV-2 Infection: Both TRIM25 and TRIM56 Positively Correlate with VEGF, GAS6, and sAXL in COVID-19 Patients6
Seroprevalence of Neutralizing Antibodies Against Candidate Serotypes of Enterovirus Vaccines Among Korean Children6
An Improved DNA Vaccine Against Bovine Herpesvirus-1 Using CD40L and a Chemical Adjuvant Induces Specific Cytotoxicity in Mice6
Influence of Pattern Recognition Receptor Ligands on Induction of Innate Immunity and Control of Hepatitis B Virus Infection5
The Improvement of Immune Effect of Recombinant Human Beta-Defensin 2 on Hepatitis B Vaccine in Mice5
A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19–Recovered Patients5
Effects of AIM2 and IFI16 on Infectious Diseases and Inflammation5
Clinical Significance of BTLA and HVEM Expression on Circulating CD4+ T and CD8+ T Cells in Chronic Hepatitis B Virus Infection5
Hepatitis B Virus Infection Promotes M2 Polarization of Macrophages by Upregulating the Expression of B7x In Vivo and In Vitro5
Genetic Association of Interleukin-6 Polymorphism (rs1800796) with Chronic Hepatitis B Virus Infection in Chinese Han Population5
TLR9 in the Human Papilloma Virus Infections: Friend or Foe?5
Red Blood Cell Malfunction in COVID-19: Molecular Mechanisms and Therapeutic Targets5
Evidence for Increased Inflammatory Cytokine Profile in Hepatitis E Virus-Infected Obese Patients: Implications for Chronic Liver Disease5
Genetic Polymorphism in Toll-Like Receptor 3 and Interferon Regulatory Factor 3 in Hepatitis C Virus-Infected Patients: Correlation with Liver Cirrhosis5
TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome5
Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma5
The Structural Features of Henipavirus Matrix Protein Driving Intracellular Trafficking5
The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes5
Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy5
The Role of Immune Regulatory Molecules in COVID-195
Pathway of Cell Death and Its Role in Virus Infection5
Liver Damage and Exposure to Toxic Concentrations of Endogenous Retinoids in the Pathogenesis of COVID-19 Disease: Hypothesis5
Spatial and Temporal Distribution of Hepatitis A Virus and Hepatitis E Virus Among Children with Acute Hepatitis in Mexico5
Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials5
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-25
SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination5
Hepatitis B Virus Might Be Sensed by STING-Dependent DNA Sensors and Attenuates the Response of STING-Dependent DNA Sensing Pathway in Humans with Acute and Chronic Hepatitis B Virus Infection5
Investigation of Fas (APO-1)-Related Apoptosis in Piglets Intradermally or Intramuscularly Vaccinated with a Commercial PRRSV MLV4
Review of Clinical Performance of Serology Based Commercial Diagnostic Assays for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies4
Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients4
Cross-Neutralization of Vanguard C4 Vaccine Against Australian Isolates of Canine Parvovirus Variants CPV-2a, CPV-2b, and CPV-2c4
Letter to the Editor: Issues on COVID-19 Pathogenesis4
Dual Roles of Tumor Necrosis Factor Superfamily 14 in Antiviral Immunity4
Poly(Lactide-co-Glycolide) Nanoparticle-Mediated Vaccine Delivery of Encapsulated Surface Antigen Protein of Hepatitis B Virus Elicits Effective Immune Response4
The FOXP3-924 A/G Single Nucleotide Polymorphism May Be Associated with Predictive Factors for Human T Lymphotropic Virus 1 Associated Myelopathy4
Correction to: The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses by Ramírez Hernández et al. Viral Immunol. 2021;34(3):165–1734
Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-194
Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages4
Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors4
Seroprevalence Investigation of Classic Swine Fever Virus Before, During, and After African Swine Fever Virus Outbreak in Some Provinces of China from 2017 to 20214
Vaccination Hesitancy and Postacute Sequelae of SARS-CoV-2: Is It Time to Reconsider?4
Elevated Levels of Cytotoxicity, Cytokines, and Anti-SARS-CoV-2 Antibodies in Mild Cases of COVID-194
Imbalance Between Soluble and Membrane-Bound CD100 Regulates Monocytes Activity in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure4
Zika Virus Vaccine: The Current State of Affairs and Challenges Posed by Antibody-Dependent Enhancement Reaction4
0.081217050552368